The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on  Percutaneous cryotherapy for renal tumours.

This document replaces previous guidance on cryotherapy for renal cancers (interventional procedure guidance 207)

  • Description

    Renal cancer occurs in the lining of the very small tubes in the kidney. Cryotherapy uses cold temperatures to destroy cancer cells through the insertion of a surgical instrument that applies freezing temperatures (cryoprobe) into the tumour.

  • OPCS4.6 Code(s)

    M13.8 Other specified percutaneous puncture of kidney

    Y13.2 Cryotherapy to lesion of organ NOC

    Y53.- Approach to organ under image control

    Note: Codes within category Y53.- are used as secondary codes to classify interventions that are percutaneous and require some form of image control: if the method of image control is unspecified, Y53.9 Unspecified approach to organ under image control is assigned.  

    In addition ICD-10 codes C64.X Malignant neoplasm of kidney, except renal pelvis, C65.X Malignant neoplasm of renal pelvis orC79.0 Secondary malignant neoplasm of kidney and renal pelvis are assigned for renal malignancies or D30.0 Benign neoplasm of kidney or D30.1 Benign neoplasm of renal pelvis for benign neoplasms of the kidney.

    The NHS Classifications Service of NHS Connecting for Health is the central definitive source for clinical coding guidance and determines the coding standards associated with the classifications (OPCS-4 and ICD-10) to be used across the NHS.   The NHS Classifications Service and NICE work collaboratively to ensure the most appropriate classification codes are provided.

  • Get involved